Close

Analyst Ratings for Vir Biotechnology (VIR)

VIR Rating Summary

VIR Price Target Summary

* Over Last 12-Mos
  |   Expand Research on VIR
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: $71.44 (+291.3%) * Over Last 12-Mos
Rating Score: 6.7 / 10   Percentile Rank: 69%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
9/14/2022 SVB Leerink Roanna Ruiz New Coverage Outperform
(N/A)
40.00
(N/A)
20.57
(18.26)
-11.23% Details
9/9/2022 Morgan Stanley Andrew Galler New Coverage Underweight
(N/A)
15.00
(N/A)
22.02
(18.26)
-17.08% Details
Like VIR Ratings? Also take a look at GSK, CPT, MTDR, PBCT

VIR Ratings News